Promising cell study provides hope of effective treatment of Parkinson's disease

April 24, 2018, Aarhus University

For the first time, medical doctors and researchers could alleviate serious symptoms of Parkinson's disease, which causes shaking, muscle stiffness and slow movements in those affected. However, before these symptoms appear, and during the course of the disease, many patients experience sleep disorders, gastrointestinal problems, anxiety and depression. Unlike the symptoms in the motor system, there is no effective treatment for these more neglected symptoms.

A team of researchers from Aarhus University has now moved a step closer to understanding how the early symptoms occur—and possibly also how they can be checked. In the study, which has just been published in the scientific journal EMBO Reports, the researchers show that in with the same type of stress as Parkinson's , there is a marked loss of . If the level of calcium decreases, cannot function. This is especially true for people at an early stage of Parkinson's disease, because malfunctioning nerve cells can give rise to symptoms such as and anxiety. According to the lead author of the study Cristine Betzer from the brain research centre DANDRITE at Aarhus University, saving calcium-depleted nerve cells indicates that the symptoms can be inhibited.

"The study indicates that the treatment of calcium disturbances is meaningful because the nerve cells are protected. This may help to prevent the disease from developing into such a disabling disease as would otherwise be the case," says Cristine Betzer.

One characteristic of Parkinson's disease is the loss of fine motor control. This happens when protein structures in the brain clump together and kill off nerve cells. By examining brain tissue from mice, pigs and humans, Betzer discovered that the clumped proteins activate a calcium pump. When this happens, the cells cannot function normally and eventually die. The researchers sought to inhibit the activation of the pump in the first place.

In Aarhus, they suppressed the pump in a worm model that was modified to express human genes. "Experiments in the United States with similar models have shown that once the worms with the Parkinson's protein have lived for eight days, their nerve cells begin to die. In our study, we treated the worms with an inhibitor against the calcium pump and then counted the nerve cells in the worms. And there were many cells left, which is a sensational and encouraging result," says Betzer. She emphasises that the result cannot be directly transposed to humans, but it is a positive indication for upcoming studies with mice and rats. "It's a question of regulating calcium in the nerve cells. This is complicated, but also a promising area, as there are already a large number of medications for regulating calcium. It's possible that the knowledge that already exists about the medications can help us make progress quicker in the new area."

She hopes that the study will offer new opportunities for treating Parkinson's disease, particularly for people who suffer from severe sleep disorders and cognitive disorders. "Our study points toward the usefulness of treating patients throughout the whole course of the disease, as the will otherwise continue to pump and thus contribute to the patient's symptoms. Perhaps the protection of cells can also mean that the damage caused by Parkinson's disease in the brain does not develop as severely as it otherwise would," says Betzer.

Explore further: Restless sleep may be an early sign of Parkinson's disease

More information: Cristine Betzer et al, Alpha‐synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation, EMBO reports (2018). DOI: 10.15252/embr.201744617

Related Stories

Restless sleep may be an early sign of Parkinson's disease

December 6, 2017
Restless sleep could be a sign of a disorder associated with diseases of the brain. Researchers from Aarhus University conducted a case-control study on the condition of the dopamine-producing nerve cells in the brain and ...

Calcium may play a role in the development of Parkinson's disease

February 19, 2018
Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson's disease.

New method maps the dopamine system in Parkinson's patients

February 14, 2018
With the aid of a PET camera, researchers from Karolinska Institutet in Sweden have developed a new method for investigating the dopamine system in the brains of patients suffering from Parkinson's disease. The method measures ...

Study uncovers cause of cell death in Parkinson's disease

February 26, 2018
A University of Guelph researcher has discovered one of the factors behind nerve cell death in Parkinson's disease, unlocking the potential for treatment to slow the progression of this fatal neurodegenerative disorder.

Shedding a tear may help diagnose Parkinson's disease

February 22, 2018
Tears may hold clues to whether someone has Parkinson's disease, according to a preliminary study released today that will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21 to ...

Hunting down the trigger for Parkinson's: Failing dopamine pump damages brain cells

June 16, 2014
A study group at the Medical University of Vienna's Centre for Brain Research has investigated the function of an intracellular dopamine pump in Parkinson's patients compared to a healthy test group. It turned out that this ...

Recommended for you

Gene therapy shown to remove core component of Parkinson's disease

September 14, 2018
An international team led by Rush researcher Jeffrey Kordower, Ph.D., has moved a step closer to developing a treatment to clear brain cells of a protein that is an integral cause of Parkinson's disease. The team published ...

ADHD may increase risk of Parkinson's disease and similar disorders

September 12, 2018
While about 11 percent of children (4-17 years old) nationwide have been diagnosed with attention-deficit hyperactivity disorder (ADHD), the long-term health effects of having ADHD and of common ADHD medications remains understudied. ...

New high-throughput screening study may open up for future Parkinson's disease therapy

September 11, 2018
Parkinson's disease (PD) is the most common movement disorder in the world. PD patients suffer from shaking, rigidity, slowness of movement and difficulty with walking. It is a neurodegenerative disease caused by the loss ...

Marmosets serve as an effective model for non-motor symptoms of Parkinson's disease

September 5, 2018
Small, New World monkeys called marmosets can mimic the sleep disturbances, changes in circadian rhythm, and cognitive impairment people with Parkinson's disease develop, according to a new study by scientists at Texas Biomedical ...

Novel brain network linked to chronic pain in Parkinson's disease

August 28, 2018
Scientists have revealed a novel brain network that links pain in Parkinson's disease (PD) to a specific region of the brain, according to a report in the journal eLife.

Sensor array may detect de novo Parkinson's disease in breath

August 27, 2018
(HealthDay)—A sensor array has the potential to identify de novo Parkinson's disease (PD) patients with high sensitivity, specificity, and accuracy values, according to a research letter published online July 10 in ACS ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.